Current Edition

Applies

GSK Applies in Japan for Approval of a Once-Daily, Single Inhaler Triple Therapy for COPD

First filing made for a triple therapy for chronic obstructive pulmonary disease offered in a single inhaler. Chronic obstructive pulmonary disease (COPD) affects over five …

Continue Reading →